TIA Pipeline Accelerator Voucher 2019-2020 - Glytherix

Project Member(s): Ralph, P., Huang, E.

Funding or Partner Organisation: Therapeutic Innovation Australia (Australian Therapeutic Pipeline)
GlyTherix Ltd (Glytherix)
GlyTherix Ltd (Glytherix)
Department of Innovation, Industry, Science & Research (National Collaborative Research Infrastructure Strategy)

Start year: 2020

Summary: Production and Lead Selection of Humanised Anti-Glypican-1 Antibodies

FOR Codes: Human Pharmaceutical Treatments (e.g. Antibiotics), Medical Molecular Engineering of Nucleic Acids and Proteins